Amrubicin for non-small-cell lung cancer and small-cell lung cancer-Reference-Cited by-同舟云学术

Amrubicin for non-small-cell lung cancer and small-cell lung cancer

Published:2007-07-13 Issue:5 Volume:25 Page:499-504
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Kurata Takayasu,Okamoto Isamu,Tamura Kenji,Fukuoka Masahiro

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-007-9069-0.pdf

Reference21 articles.

1. Yamaoka T, Hanada M, Ichii S et al (1998) Cytotoxicity of amrubicin, a novel 9-aminoanthracycline, and its metabolite amrubicinol on human tumor cells. Jpn J Cancer Res 89:1067–1073

2. Noguchi T, Ichii S, Yamaoka T et al (1998) In vivo efficacy and tumor-selective metabolism of amrubicin to its active metabolite. Jpn J Cancer Res 89:1055–1060

3. Suzuki T, Minamide S, Iwasaki T et al (1997) Cardiotoxicity of a new anthracycline derivative (SM5887) following intravenous administration to rabbits: comparative study with doxorubicin. Invest New Drugs 15:219–225

4. Morisada S, Yanagi Y, Noguchi T et al (1989) Antitumor activities of a novel 9-aminoanthracycline (SM5887) against mouse experimental tumors and human tumor xenografts. Jpn J Cancer Res 80:69–76

5. Noguchi T, Ichii S, Morisada S et al (1999) Evaluation of amrubicin with a 5 day administration schedule in a mouse model. Gan To Kagaku Ryoho 26:1305–1312

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer Therapeutics;Genes;2024-05-27

2. Evaluation of cardiotoxicity of anthracycline‐containing chemotherapy regimens in patients with bone and soft tissue sarcomas: A study of the FDA adverse event reporting system joint single‐center real‐world experience;Cancer Medicine;2023-12

3. Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming;Molecular Aspects of Medicine;2023-10

4. Anthracycline in Medicinal Chemistry: Mechanism of Cardiotoxicity, Preventive and Treatment Strategies;Current Organic Chemistry;2023-02

5. Clinical impact of amrubicin monotherapy in patients with relapsed small cell lung cancer: a multicenter retrospective study;Translational Lung Cancer Research;2022-09